World’s First Tooth Regrowth Drug To Soon Treat Humans

Image generated on AI  

The world of dentistry is gnawing into the cusp of a revolution. Just months away, Kyoto University Hospital will launch the first-ever human trials of a drug designed to regrow teeth.

Scheduled for September 2024 to August 2025, the trial will involve 30 male participants aged 30 to 64 who are missing at least one molar. Researchers aim to assess the drug’s efficacy in human subjects after its promising results in ferrets and mice. Led by a team from Toregem Biopharma and the Kitano Hospital, it has the potential to bring forth a groundbreaking alternative to root canals, implants, and dentures.

The drug targets a specific protein called USAG-1, which plays a role in suppressing tooth development. This protein acts as a natural inhibitor of tooth growth. By deactivating USAG-1, the medication encourages bone morphogenetic protein (BMP) signaling, a crucial pathway for stimulating new bone formation.

Pre-clinical trials on mice and ferrets have shown promising results, with subjects successfully growing new teeth after receiving the treatment.

If successful, this invention could offer tooth regrowth solutions for patients within the next six years.

[via New Atlas and Health News, cover image generated on AI]